The Use of Near-Infrared Light-Emitting Fluorescent Nanodiamond Particles to Detect Ebola Virus Glycoprotein: Technology Development and Proof of Principle

References

• Salata C, Calistri A, Alvisi G, Celestino M, Paroli C, Palu G. Ebola virus entry: from molecular characterization to drug discovery. Viruses. 2019;11(3):274–294.
   PubMed Web of Science ®Google Scholar
• Biedron C, Lyman M, Stuckey MJ, et al. Evaluation of infection prevention and control readiness at frontline health care facilities in high-risk districts bordering Ebola virus disease-affected areas in the Democratic Republic of the Congo - Uganda, 2018. MMWR. 2019;68(39):851–854.31581162
   PubMed Web of Science ®Google Scholar
• Holding M, Ihekweazu C, Stuart JM, Oliver I. Learning from the epidemiological response to the 2014/15 Ebola virus disease outbreak. J Epidemiol Glob Health. 2019;9(3):169–175.31529934
   PubMed Web of Science ®Google Scholar
• Gostin LO, Tomori O, Wibulpolprasert S, et al. Toward a common secure future: four global commissions in the wake of ebola. PLoS Med. 2016;13(5):e1002042.27195954
   PubMed Web of Science ®Google Scholar
• Dzau VJ, Sands P. Beyond the Ebola battle – winning the war against future epidemics. N Engl J Med. 2016;375(3):203–204.27276419
   PubMed Web of Science ®Google Scholar
• Tembo J, Simulundu E, Changula K, et al. Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease. Expert Rev Mol Diagn. 2019;19(4):325–340.30916590
   PubMed Web of Science ®Google Scholar
• Fleck F. Rapid Ebola tests hold promise. Bull World Health Organ. 2015;93(4):215–216.26229184
   PubMed Web of Science ®Google Scholar
• Vogel G. Infectious diseases. Testing new Ebola tests. Science. 2014;345(6204):1549–1550.25258059
   PubMed Web of Science ®Google Scholar
• Urassa W, Meurant R, Wood D. ReEBOV antigen rapid test kit for Ebola. Lancet. 2015;386(10010):2253–2254.26681286
   PubMedGoogle Scholar
• Banerjee R, Jaiswal A. Recent advances in nanoparticles-based lateral flow immunoassay as a point of care diagnostic tool for infectious agents and disease. Analyst. 2018;143(9):1970–1996.29645058
   PubMed Web of Science ®Google Scholar
• Duan D, Fan K, Zhang D, et al. Nanozyme-strip for rapid local diagnosis of Ebola. Biosens Bioelectron. 2015;74:134–141.26134291
   PubMed Web of Science ®Google Scholar
• Brangel P, Sobarzo A, Parolo C, et al. A serological point-of-care test for the detection of IgG antibodies against Ebola virus in human survivors. ACS Nano. 2018;12:63–73.29303554
   PubMed Web of Science ®Google Scholar
• Say JM, van Vreden C, Reilly DJ, Brown LJ, Rabeau JR, King NJC. Luminescence nanodiamonds for biological applications. Biophys Rev. 2011;3(4):171–184.28510046
   PubMedGoogle Scholar
• Pashchenko O, Shelby T, Banerjee T, Santra S. A comparison of optical, electrochemical, magnetic, and colorimetric point-of-care biosensors for infectious disease diagnosis. ACS Infect Dis. 2018;4(8):1162–1178.29860830
   PubMed Web of Science ®Google Scholar
• Purdey MS, Thompson JG, Monro TM, Abell AD, Schartner EP. A dual sensor for pH and hydrogen peroxide using polymer-coated optical fibre tips. Sensors (Basel). 2015;15(12):31904–31913.26694413
   PubMed Web of Science ®Google Scholar
• Lidke DS, Arndt-Jovin DJ. Imaging takes a quantum leap. Physiology(Bethesda). 2004;19:322–325.15546848
   PubMedGoogle Scholar
• Qasim M, Lim D-J, Park H, Na D. Nanotechnology for diagnosis and treatment of infectious diseases. J Nanosci Nanotechnol. 2014;14(10):7374–7387.25942798
   PubMed Web of Science ®Google Scholar
• Myers FB, Lee LP. Innovations in optical microfluidic technologies for point-of-care diagnostics. Lab Chip. 2008;8(12):2015–2031.19023464
   PubMed Web of Science ®Google Scholar
• Takemura K, Adegoke O, Takahashi N, et al. Versatility of a localized surface plasmon resonance-based gold nanoparticle-alloyed quantum dot nanobiosensor for immunofluorescence detection of viruses. Biosens Bioelectron. 2017;89(Pt 2):998–1005.27825520
   PubMedGoogle Scholar
• Lee SF, Osborne MA. Photodynamics of a single quantum dot: fluorescence activation, enhancement, intermittency, and decay. J Am Chem Soc. 2007;129(29):8936–8937.17608479
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz C, Gerstenhaber JA, Sternberg M, Lelkes PI, Feuerstein G. Bitistatin-functionalized fluorescent nano-diamond particles specifically bind to purified human platelet integrin receptor αIIbβ3 and activated platelets. Int J Nanomedicine. 2017;12:3711–3720.28553109
   PubMed Web of Science ®Google Scholar
• Gerstenhaber JA, Barone FC, Marcinkiewicz Cet al. Vascular thrombus imaging in vivo via near infra-red fluorescent nanodiamond particles bioengineered with the disintegrin bitistatin (Part II). Int J Nanomedicine. 2017;12:8471–8482.29200855
   PubMed Web of Science ®Google Scholar
• Torelli MD, Nunn NA, Shenderova OA. A perspective on fluorescent nanodiamond bioimaging. Small. 2019;15(48):e1902151.31215753
   PubMed Web of Science ®Google Scholar
• Reineck P, Gibson BC. Near-infrared fluorescent nanomaterials for bioimaging and sensing. Adv Optical Mater. 2017;5(2):1–26.
   Web of Science ®Google Scholar
• Turcheniuk K, Mochalin VN. Biomedical applications of nanodiamonds (Review). Nanotechnology. 2017;28(25):252001.28368852
   PubMed Web of Science ®Google Scholar
• Murin CD, Fusco ML, Bornholdt ZA, et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc Natl Acad Sci. 2014;111(48):17182–17187.25404321
   PubMed Web of Science ®Google Scholar
• Saphire EO, Schendel SL, Fusco ML, et al. Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection. Cell. 2018;174(4):938–952.30096313
   PubMed Web of Science ®Google Scholar
• Vu H, Shulenin S, Grolla A, et al. Quantitative serology assays for determination of antibody responses to ebola virus glycoprotein and matrix protein in nonhuman primates and humans. Antiviral Res. 2016;126:55–61.26681387
   PubMed Web of Science ®Google Scholar
• Warfield KL, Bosio CAM, Welcher BC, et al. Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci USA. 2003;100(26):15889–15894.14673108
   PubMed Web of Science ®Google Scholar
• Carra JH, Martins KAO, Schokman RD, Robinson CG, Steffens JT, Bavari S. A thermostable, chromatographically purified Ebola nano-VLP vaccine. J Transl Med. 2015;13:228.26174690
   PubMed Web of Science ®Google Scholar
• Singh B, Ganguly A, Sunwoo HH. Current and future diagnostic tests for Ebola virus disease. J Pharm Pharm Sci. 2016;19(4):530–551.28057165
   PubMedGoogle Scholar
• Nouvellet P, Garske T, Mills HL, et al. The role of rapid diagnostics in managing Ebola epidemics. Nature. 2015;528(7580):S109–S116.26633764
   PubMed Web of Science ®Google Scholar
• Jean Louis F, Huang JY, Nebie YK, et al. Implementation of broad screening with Ebola rapid diagnostic tests in Forécariah, Guinea. Afr J Lab Med. 2017;6(1):484.28879148
   PubMed Web of Science ®Google Scholar
• Frieden TR. Still not ready for Ebola. Science. 2018;360(6393):1049.29880661
   PubMed Web of Science ®Google Scholar
• Coarsey CT, Esiobo N, Narayan R, et al. Strategies in Ebola virus disease (EVD) diagnostics at the point of care. Crit Rev Microbiol. 2017;43(6):779–798.28440096
   PubMed Web of Science ®Google Scholar
• Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Pre-symptomatic transmission of SARS-CoV-2 – Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411–415.32271722
   PubMed Web of Science ®Google Scholar